The Effects of Angiotensin II or Angiotensin 1-7 on Rat Pial Microcirculation during Hypoperfusion and Reperfusion Injury: Role of Redox Stress

Biomolecules. 2021 Dec 10;11(12):1861. doi: 10.3390/biom11121861.

Abstract

Renin-angiotensin systems produce angiotensin II (Ang II) and angiotensin 1-7 (Ang 1-7), which are able to induce opposite effects on circulation. This study in vivo assessed the effects induced by Ang II or Ang 1-7 on rat pial microcirculation during hypoperfusion-reperfusion, clarifying the mechanisms causing the imbalance between Ang II and Ang 1-7. The fluorescence microscopy was used to quantify the microvascular parameters. Hypoperfusion and reperfusion caused vasoconstriction, disruption of blood-brain barrier, reduction of capillary perfusion and an increase in reactive oxygen species production. Rats treated with Ang II showed exacerbated microvascular damage with stronger vasoconstriction compared to hypoperfused rats, a further increase in leakage, higher decrease in capillary perfusion and marker oxidative stress. Candesartan cilexetil (specific Ang II type 1 receptor (AT1R) antagonist) administration prior to Ang II prevented the effects induced by Ang II, blunting the hypoperfusion-reperfusion injury. Ang 1-7 or ACE2 activator administration, preserved the pial microcirculation from hypoperfusion-reperfusion damage. These effects of Ang 1-7 were blunted by a Mas (Mas oncogene-encoded protein) receptor antagonist, while Ang II type 2 receptor antagonists did not affect Ang 1-7-induced changes. In conclusion, Ang II and Ang 1-7 triggered different mechanisms through AT1R or MAS receptors able to affect cerebral microvascular injury.

Keywords: angiotensin II; angiotensin-1-7; cerebral microcirculation; hypoperfusion–reperfusion; renin–angiotensin system.

MeSH terms

  • Angiotensin I / administration & dosage*
  • Angiotensin I / adverse effects
  • Angiotensin II / administration & dosage*
  • Angiotensin II / adverse effects
  • Animals
  • Benzimidazoles / administration & dosage*
  • Benzimidazoles / pharmacology
  • Biphenyl Compounds / administration & dosage*
  • Biphenyl Compounds / pharmacology
  • Female
  • Male
  • Microcirculation / drug effects
  • Microscopy, Fluorescence
  • Peptide Fragments / administration & dosage*
  • Peptide Fragments / adverse effects
  • Pia Mater / blood supply*
  • Pia Mater / drug effects
  • Pia Mater / metabolism
  • Proto-Oncogene Mas / metabolism
  • Rats
  • Reactive Oxygen Species / metabolism
  • Reperfusion Injury / drug therapy
  • Reperfusion Injury / metabolism*
  • Tetrazoles / administration & dosage*
  • Tetrazoles / pharmacology

Substances

  • Benzimidazoles
  • Biphenyl Compounds
  • Peptide Fragments
  • Proto-Oncogene Mas
  • Reactive Oxygen Species
  • Tetrazoles
  • Angiotensin II
  • Angiotensin I
  • angiotensin I (1-7)
  • candesartan cilexetil